Preliminary Safety and Efficacy Data of Daratumumab in Combination With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

GEN503 Study Group

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

Original languageEnglish
Publication dateDec 2013
Publication statusPublished - Dec 2013
EventAmerican Society of Hematology: Annual Meeting - New Orleans, USA, New Orleans, United States
Duration: 7. Dec 201313. Dec 2013

Conference

ConferenceAmerican Society of Hematology
LocationNew Orleans, USA
Country/TerritoryUnited States
CityNew Orleans
Period07/12/201313/12/2013

Cite this